Clinical Trials Browser

Phase 2 × INDUSTRY × Eye Neoplasms × Clear all

NCT04417530 2025-03-03

Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma

Phase 2 Completed

Uveal Melanoma, Eye Neoplasms